Clinical Data

Graphic image of an arrow nailing the bullseye of a target
Biotech

Exelixis beats Bayer drug in cancer trial, sending stock soaring

The overall survival win moves Exelixis a step closer to its ambition of turning the oral tyrosine kinase inhibitor into a $5 billion-a-year product.
Nick Paul Taylor Jun 23, 2025 7:30am
Weight loss

Novo's injectable amycretin yet to hit weight loss plateau

Jun 23, 2025 4:29am
overcome ladder win beat advance obstacle maze

Immuneering sees 94% survival at 6 months in pancreatic cancer

Jun 17, 2025 10:55am
weight loss scale weigh measure tape obesity overweight

Lilly's amylin data impress with 11% weight loss, tolerability

Jun 16, 2025 4:55am
Alzheimers research brain scientist magnifying glass questions neuro

NewAmsterdam links lipid drug to drop in Alzheimer's biomarker

Jun 9, 2025 8:25am
obesity overweight weight loss weigh

Metsera posts amylin data, eyes monthly GLP-1 combo

Jun 9, 2025 7:00am